Update on the Treatment of Pediatric Obsessive-Compulsive Disorder
| Autor: | Adam B. Lewin, Wayne K. Goodman, Michael J. Larson, Gary R. Geffken, Tanya K. Murphy, Eric A. Storch |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Poor prognosis High prevalence business.industry medicine.medical_treatment Psychological intervention Serotonin reuptake behavioral disciplines and activities 030227 psychiatry Exposure and response prevention 03 medical and health sciences Psychiatry and Mental health 0302 clinical medicine Pharmacotherapy Obsessive compulsive Treatment modality mental disorders medicine business Psychology Psychiatry 030217 neurology & neurosurgery |
| Zdroj: | Psychiatric Annals. 47:537-541 |
| ISSN: | 1938-2456 0048-5713 |
| DOI: | 10.3928/00485713-20171011-01 |
| Popis: | This article provides an update on the evidence base for the treatment of pediatric obsessive-compulsive disorder (OCD). Recent meta-analyses have found that cognitive-behavioral therapy (CBT) is the most efficacious monotherapy for pediatric OCD, and that serotonin reuptake inhibitors demonstrate a moderate treatment effect. There is little evidence to indicate when CBT should be combined with pharmacology, despite it being recommended for all severe cases. Although access to high-quality CBT is often limited, there is promising evidence supporting the use of intensive CBT and therapist-guided e-therapy. There is insufficient information about the efficacy and safety of second-line pharmacological interventions in pediatric populations even though they are widely used. Although existing treatments can be highly efficacious for pediatric OCD, there is a clear need to increase access to evidence-based treatments, improve response and remission rates in available treatments, and evaluate second-line interventions for treatment nonresponders. [ Psychiatr Ann. 2017;47(11):537–541.] |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|